Advertisement
Essay

Essay Essays are opinion pieces on a topic of broad interest to a general medical audience.

See all article types »

The Latest Mania: Selling Bipolar Disorder

  • David Healy
  • Published: April 11, 2006
  • DOI: 10.1371/journal.pmed.0030185
  • Featured in PLOS Collections

Reader Comments (11)

Post a new comment on this article

Profound hyperglycemia

Posted by plosmedicine on 30 Mar 2009 at 23:56 GMT

Author: Ellen Liversidge
Position: speech pathologist
Institution: school
E-mail: ebliversidge@earthlink.net
Additional Authors: no
Submitted Date: July 02, 2006
Published Date: July 3, 2006
This comment was originally posted as a “Reader Response” on the publication date indicated above. All Reader Responses are now available as comments.

The point of my letter was not, as Dr. Ghaemi seemed to imply, whether the atypical antipsychotics showed efficacy for manic depression. The point was that the drug my son was on, Zyprexa, killed him from profound hyperglycemia, with no warning from the doctor or on the label. True, he showed neither psychosis or suicidality on the drug; merely lethargy, but this is a tall price to pay for his life. Many people with serious mental illness on atypicals now have diabetes and are being poorly treated by psychiatry, which hasn't the time or expertise to treat this condition, and by medicine - hard to get when one is on Medicaid.

No medical group involved, particularly psychiatry, has addressed this problem, at least I am not aware that it has been addressed. And for sure the FDA has said nothing. So the issue of efficacy fades when one becomes stuck with not one but two serious conditions.

Competing interests declared: I have no competing interests.